If you would like to learn more about the IAEA’s work, sign up for our weekly updates containing our most important news, multimedia and more.
Technical Reports Series No. 458
English STI/DOC/010/458 ¦ 92-0-115106-3
312 pages ¦ € 56.00 ¦ Date published: 2007Radionuclide therapy employing unsealed radiotherapeutic agents has emerged as an important tool for cancer management. A number of therapeutic radiopharmaceuticals based on different types of carrier molecule and a variety of radioisotopes are currently being developed, and reliable, efficient laboratory analytical methods are needed to compare their relative effectiveness and to establish their stability and chemical, radiochemical and pharmaceutical purity. To address these issues, the IAEA organized a Coordinated Research Project on the comparative evaluation of therapeutic radiopharmaceuticals. This report summarizes the results obtained over the course of that investigation and describes, in detail, the analytical techniques, biological assays, animal tumour models and protocols for the evaluation of therapeutic radiopharmaceuticals that were established as a result. The information contained in this book will be of interest to those working in radiopharmaceutical chemistry and development, pharmacology, dosimetry and preclinical studies.
More Information on reusing IAEA copyright material.
Ordering Locally
Please use the following links for an up-to-date list of IAEA distributors:
Distributors of IAEA Publications
Orders and requests for information may also be addressed to:
Marketing and Sales Unit
International Atomic Energy Agency
Vienna International Centre
PO Box 100, A-1400 Vienna,
Austria
Tel.: +43 1 2600 22529, +43 1 2600 22530
Email: sales.publications@iaea.org
